FDA approves Diovan for cardiovascular indication
August 16, 2005Sales and Marketing
Novartis' biggest selling drug Diovan has received US approval for a new indication, as it strives to bolster its position …
Quintiles acquires site management organisation Profiad
August 11, 2005Research and Development
Contract research organisation Quintiles has acquired Profiad, a market-leading site management organisation, giving it access to the Reading-based firm clinical …
Increasing the appeal of science
August 10, 2005Research and Development
UK science students rate pharmaceutical companies as ideal employers, according to a new survey.GlaxoSmithKline, AstraZeneca and Pfizer are all rated …
New study says cancer risk from HRT only moderate
August 10, 2005Research and Development
The risk of developing breast cancer while on hormone replacement therapy may be lower than thought, according to a new …
Celebrex approved for new arthritis indication
August 8, 2005Sales and Marketing
Celebrex has received US approval for a new indication as Pfizer looks to revive tumbling sales of its flagship COX- …
DTC advertising to be tightened up
August 4, 2005Medical Communications
New US guidelines for pharmaceutical DTC advertising will come into effect next year as the industry seeks to address public …
Teva’s modest sales growth driven by MS treatment
August 4, 2005Sales and Marketing
Teva Pharmaceuticals, the world's number one generics manufacturer, has posted modest second quarter results driven by its patent-protected multiple sclerosis …
Animal rights attacks curbed by new legislation
August 4, 2005Animal rights activists have dramatically scaled back illegal attacks on medical researchers in the wake of new laws to counteract …
AstraZeneca name McKillop’s successor as sales rise
August 3, 2005Sales and Marketing
Sir Tom McKillop is to step down in January as chief executive of AstraZeneca laying to rest speculation about the …
Survival of the fittest
August 1, 2005Sales and Marketing
The title for this piece was inspired by a sort of scientific hobby I have, which revolves around critical thinking …
Personalising medicine
August 1, 2005Research and Development
Hard times have hit the drug development industry. Faced with declining returns and the apparent waning of blockbusters, coupled with …
Pfizer demands action after counterfeit Lipitor recovered in UK
July 29, 2005Manufacturing and Production
Pfizer has demanded strict new anti-counterfeiting measures in the UK and across Europe following the discovery of fake versions of …
Schering-Plough’s new anti-fungal gains EMEA approval
July 29, 2005Sales and Marketing
A new treatment for fungal infections has been given a positive opinion by the EMEA.Schering-Plough's Noxafil (posaconazole) is a novel …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
